| 产品描述: | 对EGF受体具有选择性的非酚类酪氨酸酪蛋白类似物;a non-phenolic tyrphostin analog selective for the EGF receptor;Tyrphostin RG 14620是非酚型tyrphostin类似物,对EGFR(EGF受体)具有选择性。该化合物抑制EGF刺激的HER14细胞增殖(IC | 50 | = 3μM)以及体内肿瘤的生长。Tyrphostin RG 14620对肾和膀胱癌细胞系具有抗增殖作用。Tyrphostin RG 14620是酪氨酸激酶的抑制剂。;Tyrphostin RG 14620 is a non-phenolic tyrphostin analog, which is selective for the EGFR (EGF receptor). The compound inhibits EGF-stimulated HER14 cell proliferation (IC|50|=3 μM) as well as tumor growth in vivo. Tyrphostin RG 14620 contains anti-proliferative effects on renal and bladder carcinoma cell lines. Tyrphostin RG 14620 is an inhibitor of Tyrosine Kinase. |
| 体内研究: |
RG14620 以 200 g/小鼠/天的剂量抑制裸鼠中的 H-85 肿瘤生长。与未经处理的 MH-85 荷瘤动物相比,小鼠恶病质和高钙血症较少,进食更多,并且更活跃。 |
| 参考文献: |
1. Sagara Y, et al. Tyrphostins protect neuronal cells from oxidative stress. J Biol Chem. 2002 Sep 27;277(39):36204-15. 2. Yoneda T, et al. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res. 1991 Aug 15;51(16):4430-5. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.635 ml |
18.175 ml |
36.35 ml |
| 5 mM |
0.727 ml |
3.635 ml |
7.27 ml |
| 10 mM |
0.364 ml |
1.818 ml |
3.635 ml |
| 50 mM |
0.073 ml |
0.364 ml |
0.727 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |